1207 Capital Group, LLC, an Illinois limited liability company, is an investment adviser
and is the Manager of and General Partner to Cimarron Partners, LP, Cimarron
Healthcare Opportunities, LP, Cimarron Energy Spectrum, LP, and Cimarron Venture
Opportunities, LP (each a “Client,” “Private Fund,” or “Fund,” and collectively, the
“Clients,” “Private Funds” or “Funds”). 1207 Capital Group, LLC is sometimes referred
to as the “Manager” or “firm” in this brochure. Cimarron Partners, LP, Cimarron
Healthcare Opportunities, LP, Cimarron Energy Spectrum, LP, and Cimarron Venture
Opportunities, LP are sometimes referred to together as the Private Funds, and
collectively with the Manager are sometimes referred to as Cimarron. All allocation,
direct investment and day-to-day operating decisions for the Private Funds are made by
the Manager, which is controlled by R. Mark Jernigan and owned personally or through
affiliates by R. Mark Jernigan, R. Clayton Jernigan and William F. Swee. The firm’s
growth and success is the result of an investment philosophy informed by our principal’s
substantial financial sector experience, a commitment to comprehensive due diligence,
and a considered investment process. The firm does not currently manage separate
accounts or non-U.S. funds.
Cimarron Partners, LP is a hedge fund of funds established on January 1, 2002.
Cimarron Healthcare Opportunities, LP is a hedge fund of funds established on March
1, 2013. Cimarron Energy Spectrum, LP, established on April 1, 2015, is a hedge fund
of funds that also invests directly in the equity of private operating companies. Cimarron
Venture Opportunities, LP is a venture capital fund of funds established on October 1,
2020.
Cimarron Partners, LP is a diverse-strategy, multiple-manager partnership with a
preference for relative value funds. It attempts to mitigate losses in difficult markets and
to achieve equity-like returns over the market cycle, but with lower volatility than the
broad equity markets experience. Cimarron Partners invests in multi-sector long/short
funds, specialized equity long/short funds concentrating in healthcare, energy, and
materials and mining, fixed income arbitrage, merger arbitrage, and event-driven funds
and various other strategies, which may include convertible bond arbitrage, capital
structure arbitrage, volatility arbitrage, global macro, and distressed debt. Other
strategies have been included in the portfolio in the past, and additional strategies not
listed here may be included
in the future.
Cimarron Healthcare Opportunities, LP is an equity long/short multiple-manager
partnership with a focus on providing returns in excess of equity markets over a market
cycle. Cimarron Healthcare Opportunities invests in specialized equity long/short
sector funds in healthcare and life sciences. Cimarron Healthcare Opportunities may
also, to a limited extent, make direct investments in public companies in the healthcare
and life-sciences sectors.
Cimarron Energy Spectrum, LP is a multiple-manager partnership with a focus on
providing attractive returns over a market cycle. Cimarron Energy Spectrum invests in
funds concentrating in the energy, utilities and adjacent sectors related to the transition
to sustainable energy sources, which currently include funds that pursue long/short
equity strategies and relative value strategies focused on niche commodity options
markets. Other strategies, such as hedged strategies that focus on high yield debt
instruments, including distressed debt, may be included in the future. In addition to
the above, Cimarron Energy Spectrum also participates in direct investments in
privately held operating companies and may participate in future private offerings by
these companies or other privately held companies that the General Partner identifies
as attractive investment targets.
Cimarron Venture Opportunities, LP is a multiple-manager, venture capital-style private
equity partnership that seeks to provide investors with long-term capital appreciation.
Cimarron Venture Opportunities invests in venture capital funds that specialize in the
healthcare and life sciences sectors and invest in private companies.
1207 Capital Group’s investment professionals include an Investment Committee
composed of four investment professionals. R. Mark Jernigan, founder of the firm, is the
Chair of the Investment Committee. R. Clayton Jernigan, Ronald Schutz, and William
Swee are Investment Committee members.
Given the nature of investing in a private fund, an investor may not impose investment
restrictions. Terms of the Cimarron partnerships are outlined in the Limited Partnership
Agreement and Offering Memorandum provided to all prospective investors.
As of December 31, 2023, Cimarron managed on a discretionary basis approximately
$133,800,000. Cimarron does not currently manage any non-discretionary assets. The
foregoing represents Cimarron’s net assets under management and incorporates an
estimate of the net asset value of Cimarron Venture Opportunities as of the date
specified.